HEPATIC ERYTHROPOIETIN SYNTHESIS IS ENHANCED IN HEMODIALYSIS PATIENTS WHO DO NOT REQUIRE ERYTHROPOIESIS-STIMULATING AGENTS

被引：0
|
作者：
Hirayama, Aki [1 ]
Yanagawa, Takamoto [2 ]
Kaneko, Yoko [2 ]
Nagano, Yumiko [1 ]
Owada, Shigeru [3 ]
Ishizu, Takashi [2 ]
机构：
[1] Tsukuba Univ Technol, Ctr Integrar Med, Tsukuba, Ibaraki, Japan
[2] Tsukuba Cent Hosp, Dept Nephrol, Ushiku, Japan
[3] Asa Clin, Kawasaki, Kanagawa, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0847
引用
收藏
页码：1178 / 1178
页数：1
相关论文
共 50 条
  • [41] THE USE OF PREOPERATIVE ERYTHROPOIESIS-STIMULATING AGENTS ( ESAS) IN PATIENTS WHO UNDERWENT KNEE OR HIP ARTHROPLASTY
    Alotaibi, G.
    Alsaleh, K.
    Almodaimegh, H.
    Aleem, A.
    Kouroukis, T.
    HAEMATOLOGICA, 2013, 98 : 191 - 191
  • [42] Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer
    Juneja, Vinni
    Keegan, Patricia
    Gootenberg, Joseph E.
    Rothmann, Mark D.
    Shen, Yuan Li
    Lee, Kyung Y.
    Weiss, Karen D.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2008, 14 (11) : 3242 - 3247
  • [43] EFFICACY OF ERYTHROPOIESIS-STIMULATING AGENTS IN ANEMIC PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Romanenko, N.
    Tiranova, S.
    Gritsaev, S.
    Bessmeltsev, S.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2013, 98 : 586 - 586
  • [44] Erythropoiesis-stimulating agents in cancer patients: ESMO Recommendations for use
    Scrijvers, D.
    Roila, F.
    ANNALS OF ONCOLOGY, 2009, 20 : 159 - 161
  • [45] Efficacy estimation of erythropoiesis-stimulating agents using erythropoietin-deficient anemic mice
    Suzuki, Norio
    Sasaki, Yusuke
    Kato, Koichiro
    Yamazaki, Shun
    Kurasawa, Mitsue
    Yorozu, Keigo
    Shimonaka, Yasushi
    Yamamoto, Masayuki
    HAEMATOLOGICA, 2016, 101 (09)
  • [46] Review: Erythropoiesis-stimulating agents increase mortality in patients with cancer
    Matulonis, Ursula
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (06)
  • [47] Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients
    Ngo, Katherine
    Kotecha, Dipak
    Walters, Julia A. E.
    Manzano, Luis
    Palazzuoli, Alberto
    van Veldhuisen, Dirk J.
    Flather, Marcus
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [48] Erythropoiesis-stimulating agents in patients with cancer: update on safety issues
    Pirker, Robert
    EXPERT OPINION ON DRUG SAFETY, 2009, 8 (05) : 515 - 522
  • [49] Shortened Red Blood Cell Lifespan Is Related to the Dose of Erythropoiesis-Stimulating Agents Requirement in Patients on Hemodialysis
    Sato, Yasuyuki
    Mizuguchi, Takashi
    Shigenaga, Sawako
    Yoshikawa, Etsuko
    Chujo, Keiko
    Minakuchi, Jun
    Kawashima, Syu
    THERAPEUTIC APHERESIS AND DIALYSIS, 2012, 16 (06) : 522 - 528
  • [50] Quality of Life in CKD Patients Treated With Erythropoiesis-Stimulating Agents
    Parfrey, Patrick S.
    Wish, Tyler
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (03) : 423 - 425
12345